PURE Financial Facts
Loss from operations: -1.45MSelling, general and administrative: 1.22M
See Full Income Statement
See Full Balance Sheet
Pure Bioscience (PURE) Earnings
|
Expand Research on PURE
| Next EPS Date | 6/12/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | N/A | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | N/A | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
12/15/10  |
Q111 | -$0.06 | N/A | N/A | N/A | N/A | N/A |  | | Details | |
| 3/17/11 |
 |
Q211 | -$0.07 | N/A | N/A | N/A | $3.22B | N/A | | | Details |
| 6/10/14 | Q314 | -$0.07 | N/A | N/A | $261K | $258K | N/A | | | Details | |
| 6/13/11 |
|
Q311 | -$0.05 | N/A | N/A | $128.4K | $536.5K | N/A | | | Details |
| 6/13/12 | Q312 | -$0.04 | N/A | N/A | $207K | $128M | N/A | | | Details | |
| 12/14/23 | Q323 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 10/30/23 | Q323 | -$0.04 | N/A | N/A | $1.87M | N/A | N/A | | | Details | |
| 12/15/11 |
|
Q112 | -$0.06 | N/A | N/A | $257K | $23K | N/A | | | Details |
